Literature DB >> 12700132

Focal adhesion kinase signaling activities and their implications in the control of cell survival and motility.

Steven K Hanks1, Larisa Ryzhova, Nah-Young Shin, Jan Brábek.   

Abstract

Focal adhesion kinase (FAK) was first described in 1992 as a novel nonreceptor protein-tyrosine kinase localized prominently within focal adhesions, suggesting a signaling role in regulating cell behavior resulting from integrin interaction with the extracellular matrix. Subsequent studies over the past decade have established functional roles for FAK as a positive regulator of both cell motility and cell survival, while providing considerable insight into signaling mechanisms involved. FAK signaling results from its ability to become highly phosphorylated in response to integrin-mediated adhesion on Tyr-397, permitting interactions with a number of different signaling effectors containing Src homology 2 (SH2) domains. Src-family kinases recruited to the Tyr-397 site phosphorylate two FAK-interacting proteins, Crk-associated substrate (CAS) and paxillin, which results ultimately in regulation of Rho-family GTPases contributing to cell motility. CAS phosphorylation, as well as phosphatidylinositol 3-kinase (PI3K) activation resulting from its binding to the FAK Tyr-397 site, have been implicated as downstream FAK signaling events that confer a resistance to apoptosis. This article reviews these and other aspects of FAK signaling and function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700132     DOI: 10.2741/1114

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  142 in total

1.  A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability, clonogenicity and tumor growth in vivo.

Authors:  Vita M Golubovskaya; Sheila Figel; Baotran T Ho; Christopher P Johnson; Michael Yemma; Grace Huang; Min Zheng; Carl Nyberg; Andrew Magis; David A Ostrov; Irwin H Gelman; William G Cance
Journal:  Carcinogenesis       Date:  2012-03-07       Impact factor: 4.944

Review 2.  Integrin signalling and the cellular response to ionizing radiation.

Authors:  Nils Cordes; Viktor Meineke
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

3.  Src-dependent autophagic degradation of Ret in FAK-signalling-defective cancer cells.

Authors:  Emma Sandilands; Bryan Serrels; Simon Wilkinson; Margaret C Frame
Journal:  EMBO Rep       Date:  2012-06-26       Impact factor: 8.807

4.  Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes.

Authors:  Audrey D Lafrenaye; Babette Fuss
Journal:  J Neurochem       Date:  2010-08-19       Impact factor: 5.372

5.  The ADPKD genes pkd1a/b and pkd2 regulate extracellular matrix formation.

Authors:  Steve Mangos; Pui-ying Lam; Angela Zhao; Yan Liu; Sudha Mudumana; Aleksandr Vasilyev; Aiping Liu; Iain A Drummond
Journal:  Dis Model Mech       Date:  2010-03-24       Impact factor: 5.758

Review 6.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

7.  Focal adhesion kinase (FAK)-related non-kinase inhibits myofibroblast differentiation through differential MAPK activation in a FAK-dependent manner.

Authors:  Qiang Ding; Candece L Gladson; Hongju Wu; Haurko Hayasaka; Mitchell A Olman
Journal:  J Biol Chem       Date:  2008-07-31       Impact factor: 5.157

8.  Global impact of oncogenic Src on a phosphotyrosine proteome.

Authors:  Weifeng Luo; Robbert J Slebos; Salisha Hill; Ming Li; Jan Brábek; Ramars Amanchy; Raghothama Chaerkady; Akhilesh Pandey; Amy-Joan L Ham; Steven K Hanks
Journal:  J Proteome Res       Date:  2008-06-19       Impact factor: 4.466

9.  Autophosphorylation-independent and -dependent functions of focal adhesion kinase during development.

Authors:  Jean-Marc Corsi; Christophe Houbron; Pierre Billuart; Isabelle Brunet; Karine Bouvrée; Anne Eichmann; Jean-Antoine Girault; Hervé Enslen
Journal:  J Biol Chem       Date:  2009-09-23       Impact factor: 5.157

10.  Therapeutic Potential of Focal Adhesion Kinase Inhibition in Small Cell Lung Cancer.

Authors:  Frank Aboubakar Nana; Marylène Lecocq; Maha Zohra Ladjemi; Bruno Detry; Sébastien Dupasquier; Olivier Feron; Pierre P Massion; Yves Sibille; Charles Pilette; Sebahat Ocak
Journal:  Mol Cancer Ther       Date:  2018-10-23       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.